Closing Bell Recap: CARGO Therapeutics Inc (CRGX) Ends at 3.39, Reflecting a -74.30 Downturn

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

CARGO Therapeutics Inc (NASDAQ: CRGX) closed the day trading at $3.39 down -74.30% from the previous closing price of $13.19. In other words, the price has decreased by -$74.30 from its previous closing price. On the day, 21.26 million shares were traded. CRGX stock price reached its highest trading level at $3.49 during the session, while it also had its lowest trading level at $3.0.

Ratios:

For a better understanding of CRGX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.95 and its Current Ratio is at 18.95. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.

On January 31, 2025, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $32 to $7.

Piper Sandler Downgraded its Overweight to Neutral on January 31, 2025, whereas the target price for the stock was revised from $34 to $4.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 18 ’24 when Chapman Gina sold 7,166 shares for $25.09 per share. The transaction valued at 179,775 led to the insider holds 103,905 shares of the business.

Chapman Gina sold 2,975 shares of CRGX for $74,457 on Sep 19 ’24. The President & CEO now owns 103,905 shares after completing the transaction at $25.03 per share. On Sep 18 ’24, another insider, Radhakrishnan Anup, who serves as the Chief Financial Officer of the company, sold 1,600 shares for $25.28 each. As a result, the insider received 40,452 and left with 6,446 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRGX now has a Market Capitalization of 156033904 and an Enterprise Value of -220230000.

Stock Price History:

The Beta on a monthly basis for CRGX is 2.46, which has changed by -0.4387234 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, CRGX has reached a high of $33.92, while it has fallen to a 52-week low of $10.91. The 50-Day Moving Average of the stock is -76.87%, while the 200-Day Moving Average is calculated to be -80.82%.

Shares Statistics:

Over the past 3-months, CRGX traded about 326.60K shares per day on average, while over the past 10 days, CRGX traded about 635380 shares per day. A total of 45.99M shares are outstanding, with a floating share count of 32.06M. Insiders hold about 30.34% of the company’s shares, while institutions hold 81.47% stake in the company. Shares short for CRGX as of 1736899200 were 7211835 with a Short Ratio of 22.08, compared to 1734048000 on 6048467. Therefore, it implies a Short% of Shares Outstanding of 7211835 and a Short% of Float of 18.16.

Earnings Estimates

At present, 6.0 analysts are actively evaluating the performance of CARGO Therapeutics Inc (CRGX) in the stock market.The consensus estimate for the next quarter is -$0.69, with high estimates of -$0.52 and low estimates of -$0.96.

Analysts are recommending an EPS of between -$3.45 and -$3.74 for the fiscal current year, implying an average EPS of -$3.66. EPS for the following year is -$2.08, with 6.0 analysts recommending between -$1.25 and -$3.59.

Most Popular